Citadel Advisors’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42K | Sell |
18,400
-18,200
| -50% | -$41.9K | ﹤0.01% | 12469 |
|
|
2025
Q4 | $102K | Sell |
36,600
-3,600
| -9% | -$12.9K | ﹤0.01% | 11621 |
|
|
2025
Q3 | $193K | Buy |
40,200
+10,100
| +34% | +$64.3K | ﹤0.01% | 11298 |
|
|
2025
Q2 | $274K | Buy |
30,100
+16,300
| +118% | +$120K | ﹤0.01% | 9997 |
|
|
2025
Q1 | $125K | Buy |
13,800
+4,600
| +50% | +$48.6K | ﹤0.01% | 11156 |
|
|
2024
Q4 | $120K | Sell |
9,200
-9,500
| -51% | -$127K | ﹤0.01% | 11183 |
|
|
2024
Q3 | $293K | Buy |
18,700
+1,400
| +8% | +$21.2K | ﹤0.01% | 9383 |
|
|
2024
Q2 | $234K | Sell |
17,300
-38,000
| -69% | -$778K | ﹤0.01% | 9611 |
|
|
2024
Q1 | $1.53M | Buy |
55,300
+8,000
| +17% | +$178K | ﹤0.01% | 6049 |
|
|
2023
Q4 | $911K | Buy |
47,300
+32,900
| +228% | +$596K | ﹤0.01% | 6859 |
|
|
2023
Q3 | $233K | Hold |
14,400
| – | – | ﹤0.01% | 9633 |
|
|
2023
Q2 | $274K | Buy |
14,400
+4,400
| +44% | +$78.5K | ﹤0.01% | 9240 |
|
|
2023
Q1 | $146K | Sell |
10,000
-31,100
| -76% | -$557K | ﹤0.01% | 10686 |
|
|
2022
Q4 | $803K | Buy |
41,100
+13,300
| +48% | +$259K | ﹤0.01% | 7243 |
|
|
2022
Q3 | $670K | Sell |
27,800
-1,400
| -5% | -$43.1K | ﹤0.01% | 7829 |
|
|
2022
Q2 | $918K | Sell |
29,200
-15,200
| -34% | -$551K | ﹤0.01% | 7215 |
|
|
2022
Q1 | $1.95M | Sell |
44,400
-39,100
| -47% | -$1.68M | ﹤0.01% | 6135 |
|
|
2021
Q4 | $3.63M | Sell |
83,500
-2,300
| -3% | -$90.2K | ﹤0.01% | 4950 |
|
|
2021
Q3 | $2.69M | Sell |
85,800
-53,500
| -38% | -$2.11M | ﹤0.01% | 5631 |
|
|
2021
Q2 | $5.9M | Buy |
139,300
+61,500
| +79% | +$2.39M | ﹤0.01% | 4091 |
|
|
2021
Q1 | $2.92M | Sell |
77,800
-71,200
| -48% | -$2.23M | ﹤0.01% | 5509 |
|
|
2020
Q4 | $4.03M | Buy |
149,000
+103,800
| +230% | +$2.67M | ﹤0.01% | 4049 |
|
|
2020
Q3 | $1.14M | Buy |
+45,200
| New | +$659K | ﹤0.01% | 5813 |
|
|
2020
Q2 | – | Sell |
-19,700
| Closed | -$180K | – | 10294 |
|
|
2020
Q1 | $180K | Sell |
19,700
-14,200
| -42% | -$85.7K | ﹤0.01% | 8116 |
|
|
2019
Q4 | $175K | Buy |
33,900
+4,400
| +15% | +$28.3K | ﹤0.01% | 8276 |
|
|
2019
Q3 | $171K | Buy |
29,500
+5,300
| +22% | +$23.8K | ﹤0.01% | 8238 |
|
|
2019
Q2 | $77K | Buy |
24,200
+5,200
| +27% | +$17.7K | ﹤0.01% | 8612 |
|
|
2019
Q1 | $78K | Sell |
19,000
-41,900
| -69% | -$265K | ﹤0.01% | 8646 |
|
|
2018
Q4 | $385K | Sell |
60,900
-27,600
| -31% | -$287K | ﹤0.01% | 6846 |
|
|
2018
Q3 | $1.46M | Buy |
88,500
+36,200
| +69% | +$615K | ﹤0.01% | 4907 |
|
|
2018
Q2 | $874K | Buy |
52,300
+10,300
| +25% | +$167K | ﹤0.01% | 5455 |
|
|
2018
Q1 | $653K | Buy |
42,000
+26,400
| +169% | +$471K | ﹤0.01% | 5443 |
|
|
2017
Q4 | $295K | Buy |
+15,600
| New | +$346K | ﹤0.01% | 6494 |
|
|
2016
Q2 | – | Sell |
-7,600
| Closed | -$307K | – | 7227 |
|
|
2016
Q1 | $307K | Sell |
7,600
-3,100
| -29% | -$115K | ﹤0.01% | 5066 |
|
|
2015
Q4 | $385K | Buy |
10,700
+10,500
| +5,250% | +$380K | ﹤0.01% | 4840 |
|
|
2015
Q3 | $6K | Buy |
+200
| New | +$6.81K | ﹤0.01% | 8599 |
|
Other funds holding ACH
CCM
ICM
VCM
VPM
Citadel Advisors's ACH Position: Q1 2026 in Review
Citadel Advisors reduced its Accendra Health (ACH) stake by 86% in Q1 2026, selling an estimated $3.19M and leaving 235,139 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #9131.
Citadel Advisors first reported a position in ACH in Q2 2013 and has held it in 47 quarters since. The position peaked at $57.6M in Q4 2021. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.
- Citadel Advisors held 235,139 shares of Accendra Health worth $536K as of Q1 2026.
- Citadel Advisors sold 1,386,872 Accendra Health shares in Q1 2026, an estimated $3.19M.
- Accendra Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9131 holding.
- Citadel Advisors first reported a position in Accendra Health in Q2 2013 and has held it in 47 quarters since.
- Citadel Advisors's Accendra Health position peaked at $57.6M in Q4 2021.
- 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.